Revenue Growth YoY (Last 12 Months): Teleflex Corp (TFX)

Public company logo of Teleflex Incorporated (TFX)

Teleflex Incorporated (TFX) relies on stable demand for surgical consumables, which ensures a predictable cash flow. The YoY commercial revenue growth for the LTM reflects the current trend, with the indicator reaching -29.20. Outlook depends on regulatory approvals and hospital budgets, while experienced management effectively executes M&A transactions to accelerate internal business development.

Teleflex Corp (TFX) Sales Growth YoY (Last Twelve Months): for the period 02/11/2024 - 11/15/2026

Summary analytical data breakdowns for Teleflex Inc. (TFX)

- market price and analyst price targets:
Stock Price Teleflex Corp|TFX - Price Target Chart
- company stock exchange capitalization indicators:
Market Valuation Teleflex Incorporated|TFX - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share Teleflex|TFX - Company Book Value|Capitalization to Book Value Ratio teleflex.com|TFX - Cumulative Company Assets
- business debt structure and liquidity details:
Aggregate Debt to Capital Teleflex Incorporated|TFX - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Teleflex Inc|TFX - Company Total Debt|Debt to Book Capital Teleflex Incorporated|TFX - Company Long-Term Debts|Short-Term Debt Teleflex|Quick Liquidity teleflex.com
- earnings and market multiples details:
TFX - Net Profit|Expected Net Profit Teleflex Incorporated|TFX - P/E Multiple|Price to Expected Earnings Ratio teleflex.com|TFX - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Teleflex Incorporated|TFX - Operating profit EBITDA|Net earnings per one share for the last twelve months Teleflex|TFX - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last 12 months teleflex.com|TFX - Net earnings per share growth this year|Expected earnings per share trend next year Teleflex Incorporated
- sales and revenue data:
TFX - Revenue and Sales Volume|Company Future Sales Teleflex Corp|TFX - Price-to-Revenue Ratio|Market Cap to Projected Revenue Teleflex Incorporated|TFX - Sales Growth YoY (TTM)
Fundamental company valuation:Teleflex Inc TFX
Product sample of Teleflex

Selecting fundamentally resilient assets begins with an analysis of revenue dynamics. This indicator measures the percentage change in total income over the last 12 months, allowing for an assessment of the actual speed of business expansion. For Teleflex Incorporated (TFX), this confirms the effectiveness of the transition toward high-margin surgical instruments and urological devices. By evaluating comparable year-over-year sales growth over 12 months, an investor can see the scaling pace of the company's modern product catalog.

Who Teleflex Incorporated competes with

Revenue Dynamics YoY (Last Twelve Months) ISRG|DHR - Sales Growth YoY (Last Twelve Months)|Becton Dickinson & Co (BDX) - Revenue Growth YoY (Last 12 Months)|STE: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth West Pharma (WST)|Sales Growth YoY (Last Twelve Months) Baxter International|Trailing Twelve Months Revenue Growth Masimo Inc. MASI|Sales Growth YoY (Last Twelve Months) Stevanato Group (STVN)|Merit Medical - Sales Growth YoY (Last 12 Months)|Envista Holdings - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) ICUI (ICU Medical Inc)|XRAY - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) LeMaitre Corp LMAT|ATRC: Sales Growth YoY (TTM)|STAA - Annual Revenue Growth (Last Twelve Months)|NAGE (Chromadex Corp) - Sales Growth YoY (TTM)|ZimVie Inc (ZIMV) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) ANGO|CERS (Cerus Corporation) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) TKNO (Alpha Teknova, Inc.)|Monogram Technologies (MGRM) - Trailing Twelve Months Revenue Growth|STSS - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) InfuSystem INFU|Utah Med (UTMD) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) KORU Medical Systems, Inc.|Revenue Growth YoY (Last 12 Months) NYXH|Trailing Twelve Months Revenue Growth Microbot Medical MBOT|Revenue Growth YoY (Last 12 Months) PDEX (Pro-Dex)|Sales Growth YoY (Last Twelve Months) ZTEK (Zentek Limited)|Sales Growth YoY (Last Twelve Months) Elutia Inc. ELUT|Milestone Scientific (MLSS) - Trailing Twelve Months Revenue Growth|nexgel.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Retractable Technologies Inc.|Harvard Bioscience Inc. (HBIO) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) Femasys Corp|Revenue Growth YoY (Last 12 Months) MHUA|Trailing Twelve Months Revenue Growth predictive-oncology.com POAI|Sales Growth YoY (Last Twelve Months) Callan JMB Corp (CJMB)|ATRI (Atrion Corporation) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) NeuroMetrix Corp NURO